Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

The independently developed "COVID-19 antigen detection kit SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit (Colloidal gold method)" by Synthgene Medical Technology was approved by the UK 5-year CTDA certification.

Following the broader life science tools space, proteomics firms experienced something of a retrenchment in 2022 as the boom times of the previous two years gave way to layoffs, strategic realignments, and delays.

China will scrap the quarantine requirement for international arrivals starting January 8, 2023, the country's National Health Commission said in a statement on Monday.

On December 26, Hangzhou Biotest Biotech announced that the COVID-19 antigen home self-test test kit produced by Advin, has passed laboratory verification and clinical research evaluation and has now obtained the EUA from the US Food and Drug Administration.

CTK Biotech said on Tuesday that its ImmuView COVID-19 Antigen Home Test has received Emergency Use Authorization from the US Food and Drug Administration.

In partnership with Minnesota Department of Health, Cue’s digital service offers an integrated solution to provide COVID-19 treatment options access across all populations

Recently, Chengdu Qi Tan Technology Co., Ltd. announced that it had completed the financing round C of 700 million CNY. This round of financing was led by Mei Tuan Capital, and the Capital Great Health Fund managed by HG Capital and BioTrack Capital continued to make additional investments.

Addition of next generation sequencing research panels, bioinformatics, positions IDT to become a leading oncology research solutions provider

The US Food and Drug Administration said on Thursday it has issued Emergency Use Authorizations to two over-the-counter, at-home antigen tests for detecting the SARS-CoV-2 virus.

The US Food and Drug Administration this week granted Emergency Use Authorization for OnsiteGene's Hi-Sense COVID-19 Molecular Testing Kit 1.0.